Solana Co — Director's Dealing 2016

Jan 8, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2015-12-29

Reporting Person: Peng Huaizheng (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$.90	2020-12-31	Class A Common Stock (50000)		Direct

Footnotes

F1: One-third of the shares subject to this option vested on December 31, 2015 and the remaining shares will vest in equal amounts on each of December 31, 2016 and December 31, 2017.

F2: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.3839 on December 31, 2015, based on an option exercise price of CAD$1.24.